glp-1-directed nmda receptor antagonism for obesity treatment GLP-1 Agonists and Research to Treat Overeating and Substance Use Disorders Nature: Dual-active molecules targeting GLP-1R
Pay in 4 interest-free payments of $6.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19


























